drugset / Trial / NCT01546649
A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
Hormone dynamics, pharmacokinetics, safety, and efficacy of TAP-144-SR(6M) will be evaluated against TAP-144-SR(3M) in postoperative and hormone therapy-naïve patients with premenopausal breast cancer
Timeline
- Start
- 2012-04
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | TAP-144-SR(3M) | Unknown | 11.25 mg | Other |
| Subject | TAP-144-SR(6M) | Unknown | 22.5 mg | Other |